Cited by 61Cytokine Signaling Pathways and InteractionsImmune cells in cancerT-cell and B-cell Immunology

GM-CSF: Master regulator of the T cell-phagocyte interface during inflammation

Open access
Ingelfinger, Florian, De Feo, Donatella, Becher, Burkhard·2021·Seminars in Immunology

Abstract

The role of granulocyte-macrophage colony-stimulating factor (GM-CSF) was sequentially redefined during the past decades. Originally described as a hematopoietic growth factor for myelopoiesis, GM-CSF was recognized as a central mediator of inflammation bridging the innate and adaptive arms of the immune system. Phagocytes sensing GM-CSF adapt an inflammatory phenotype and facilitate pathogen clearance. However, in the context of chronic tissue inflammation, GM-CSF secreted by tissue-invading lymphocytes has detrimental effects by licensing tissue damage and hyperinflammation. Accordingly, therapeutic intervention at the T cell-phagocyte interface represents an attractive target to ameliorate disease progression and immunopathology. Although GM-CSF is largely dispensable for steady state myelopoiesis, dysregulation, as seen in chronic inflammatory diseases, may however lead to disrupted haematopoiesis and long-term effects on bone marrow output. Here, we will survey the role of GM-CSF during inflammation, discuss the extent to which GM-CSF-secreting T cells, debate their introduction as a separate T cell lineage and explore current and future clinical implications of GM-CSF in human disease settings.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.smim.2021.101518

Cites

168 of 168 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the Il10−/− model of colitis, Th17 cells are the main immune population mediating the inflammatory response.

    “In the Il10−/− model of colitis, in which IL-10-deficient mice develop spontaneous microbiota-dependent colitis, Th17 cells were identified as the main immune population mediating the inflammatory immune response [43, 133].”

    From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [133]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

1 retracted

Flagged first, then by citations

Research works printed but not linked: 3

  1. J.L. McQualter, R. Darwiche, C. Ewing, M. Onuki, T.W. Kay, J.A. Hamilton, H. H. Reid, C.C.A. Bernard, Granulocyte macrophage colony-stimulating factor: a new putative therapeutic target in multiple sclerosis, J. Exp. Med. 194 (2001), https://doi.org/10.1084/jem.194.7.873. · DOI · Paper page
  2. K. Hirota, M. Hashimoto, Y. Ito, M. Matsuura, H. Ito, M. Tanaka, H. Watanabe, G. Kondoh, A. Tanaka, K. Yasuda, M. Kopf, A.J. Potocnik, B. Stockinger, N. Sakaguchi, S. Sakaguchi, Autoimmune Th17 cells induced synovial stromal and innate lymphoid cell secretion of the cytokine GM-CSF to initiate and augment autoimmune arthritis, Immunity 48 (6) (2018), https://doi.org/10.1016/j. immuni.2018.04.009. · DOI
  3. J. Patel, A. Beishuizen, X.B. Ruiz, H. Boughanmi, A. Cahn, G.J. Criner, K. Davy, J. de-Miguel-Díez, S. Fernandes, B. François, A. Gupta, K. Hanrott, T. Hatlen, D. Inman, J.D. Isaacs, E. Jarvis, N. Kostina, J.-C. Lacherade, P. Martinez-Ayala, C. McEvoy, R. Muñoz-Bermúdez, J. Neisen, G. Plantefeve, L. Schifano, L. Schwab, Z. Shahid, M. Shirano, J.E. Smith, E. Sprinz, C. Summers, N. Terzi, M.A. Tidswell, R. Williamson, D. Wyncoll, M. Layton, A Randomized Trial of Otilimab in Severe COVID-19 Pneumonia (OSCAR), MedRxiv, 2021.

Cited by

Sorted by citations

Authors
Ingelfinger, F., De Feo, D., & Becher, B.
Affiliations
University of Zurich (CH)
Corresponding author
Becher, Burkhard
Venue
Seminars in Immunology
Publisher
Elsevier BV
Published
2021-04
Volume
54
Pages
101518
ISSN
1044-5323 (ISSN-L)
OpenAlex
W3214090945
Cited by
61
References
168
Citations by year
2026: 13 · 2025: 10 · 2024: 12 · 2023: 11 · 2022: 15
FWCI
1.15
Type
journal article
Language
en
Open access
Locations
  • Seminars in Immunology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, cc-by-nc-nd)
  • Zurich Open Repository and Archive (University of Zurich)
Funders
  • Universität Zürich (K-41302-10-01)
  • Horizon 2020 Framework Programme (826121, 847782, 882424)
  • Schweizerische Multiple Sklerose Gesellschaft
  • European Research Council
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • Studienstiftung des Deutschen Volkes
  • Israel Ports Company
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
GM-CSF, inflammation, myelopoiesis, phagocyte activation, hyperinflammation, tissue damage, T cell lineage, hematopoiesis, innate-adaptive immune crosstalk, immunopathology, GM-CSF therapy
MeSH terms
Hematopoiesis, Humans, Inflammation, Phagocytes, T-Lymphocytes, Granulocyte-Macrophage Colony-Stimulating Factor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review